WallStreetZenWallStreetZen

NASDAQ: SUPN
Supernus Pharmaceuticals Inc Stock Ownership - Who owns Supernus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Supernus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy C. DecCFO;SVP2026-08-12604$46.57
$28.13kSell
Jack A. KhattarCEO;Pres2026-08-1212,642$46.57
$588.74kSell
Padmanabh P. BhattCSci;SVP2026-08-121,158$46.57
$53.93kSell
Jonathan RubinMed;SVP2026-08-12363$46.57
$16.90kSell
Frank MottolaCTO;SVP2026-08-12797$46.57
$37.12kSell
Padmanabh P. BhattSr. VP of IP CSO2026-03-18412$50.48
$20.80kSell
Padmanabh P. BhattSr. VP of IP CSO2026-03-187,250$39.40
$285.65kBuy
Padmanabh P. BhattSr. VP of IP CSO2026-03-186,838$49.55
$338.82kSell
Padmanabh P. BhattSr. VP of IP CSO2026-03-1722,750$39.40
$896.35kBuy
Padmanabh P. BhattSr. VP of IP CSO2026-03-1715,000$38.60
$579.00kBuy

1 of 7

SUPN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SUPN insiders and whales buy or sell their stock.

SUPN Shareholders

What type of owners hold Supernus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter J. Barris20.36%11,859,518$497.15MInsider
Scott D. Sandell20.19%11,757,336$492.87MInsider
Forest Baskett20.17%11,746,274$492.40MInsider
Charles W. Newhall Iii18.49%10,765,369$451.28MInsider
Krishna Kittu Kolluri6.60%3,841,172$161.02MInsider
Nea Partners 11 LP6.56%3,820,625$160.16MInsider
New Enterprise Associates 11 LP6.56%3,820,625$160.16MInsider
Michael B. Sheffery6.54%3,806,814$159.58MInsider
Abingworth Management Ltd6.18%3,600,000$150.91MInsider
Jack A. Khattar5.46%3,178,551$133.24MInsider

1 of 3

SUPN vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SUPN0.09%99.91%Net SellingNet Selling
PBH0.11%48.83%Net Selling
HCM0.00%0.06%
PRGO0.12%58.75%Net BuyingNet Buying
TRLV0.02%12.35%Net Selling
View Top Pharmaceutical Stocks

Supernus Pharmaceuticals Stock Ownership FAQ

Who owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals (NASDAQ: SUPN) is owned by 0.10% institutional shareholders, 120.45% Supernus Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Supernus Pharmaceuticals shareholder, owning 11.86M shares representing 20.36% of the company. Peter J. Barris's Supernus Pharmaceuticals shares are currently valued at $497.15M.

If you're new to stock investing, here's how to buy Supernus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.